Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human

被引:21
作者
Alberici, Paola
de Pater, Emma
Cardoso, Joana
Bevelander, Mieke
Molenaar, Lia
Jonkers, Jos
Fodde, Riccardo
机构
[1] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
[2] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands
关键词
D O I
10.2353/ajpath.2007.060853
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Although chromosomal instability characterizes the majority of human colorectal cancers, the contribution of genes such as adenomatous polyposis coli (APC), KRAS, and p53 to this form of genetic instability is still under debate. Here, we have assessed chromosomal imbalances in tumors from mouse models of intestinal cancer, namely Apc(+/1638N), Apc(+/1638N)/KRAS(V12G), and Apc(+/1638N)/Tp53(-/-), by array comparative genomic hybridization. All intestinal adenomas from Apc(+/1638N) mice displayed chromosomal alterations, thus confirming the presence of a chromosomal instability defect at early stages of the adenoma-carcinoma sequence. Moreover, loss of the Tp53 tumor suppressor gene, but not KRAS oncogenic activation, results in an increase of gains and losses of whole chromosomes in the Apc-mutant genetic background. Comparative analysis of the overall genomic alterations found in mouse intestinal tumors allowed us to identify a subset of loci syntenic with human chromosomal regions (eg, 1p34-p36, 12q24, 9q34, and 22q) frequently gained or lost in familial adenoma and sporadic colorectal cancers. The latter indicate that, during intestinal tumor development, the genetic mechanisms and the underlying functional defects are conserved across species. Hence, our array comparative genomic hybridization analysis of Apc-mutant intestinal tumors allows the definition of minimal aneuploidy regions conserved between mouse and human and likely to encompass rate-limiting genes for intestinal tumor initiation and progression.
引用
收藏
页码:377 / 387
页数:11
相关论文
共 73 条
[1]
Smad4 haploinsufficiency in mouse models for intestinal cancer [J].
Alberici, P ;
Jagmohan-Changur, S ;
De Pater, E ;
Van Der Valk, M ;
Smits, R ;
Hohenstein, P ;
Fodde, R .
ONCOGENE, 2006, 25 (13) :1841-1851
[2]
ALBERICI P, 2006, ROLE APC TUMOR SUPPR, P149
[3]
Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1 [J].
Andreassen, PR ;
Lohez, OD ;
Lacroix, FB ;
Margolis, RL .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) :1315-1328
[4]
Mammalian G1- and S-phase checkpoints in response to DNA damage [J].
Bartek, J ;
Lukas, J .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (06) :738-747
[5]
Genomic heterogeneity and instability in colorectal cancer: spectral karyotyping, glutathione transferase-M1 and ras [J].
Bartos, JD ;
Stoler, DL ;
Matsui, S ;
Swede, H ;
Willmott, LJ ;
Sait, SN ;
Petrelli, NJ ;
Anderson, GR .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 568 (02) :283-292
[6]
BLOUNT PL, 1994, CANCER RES, V54, P2292
[7]
Pathology of mouse models of intestinal cancer: Consensus report and recommendations [J].
Boivin, GP ;
Washington, K ;
Yang, K ;
Ward, JM ;
Pretlow, TP ;
Russell, R ;
Besselsen, DG ;
Godfrey, VL ;
Doetschman, T ;
Dove, WF ;
Pitot, HC ;
Halberg, RB ;
Itzkowitz, SH ;
Groden, J ;
Coffey, RJ .
GASTROENTEROLOGY, 2003, 124 (03) :762-777
[8]
Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas [J].
Bonner, AE ;
Lemon, WJ ;
Devereux, TR ;
Lubet, RA ;
You, M .
ONCOGENE, 2004, 23 (05) :1166-1176
[9]
Mutation analysis of EP300 in colon, breast and ovarian carcinomas [J].
Bryan, EJ ;
Jokubaitis, VJ ;
Chamberlain, NL ;
Baxter, SW ;
Dawson, E ;
Choong, DYH ;
Campbell, IG .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (02) :137-141
[10]
Mutations of mitotic checkpoint genes in human cancers [J].
Cahill, DP ;
Lengauer, C ;
Yu, J ;
Riggins, GJ ;
Willson, JKV ;
Markowitz, SD ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 392 (6673) :300-303